Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients

Bone Marrow Transplantation

Volumn 32, Issue 10, 2003, Pages 1001-1014

  Fallen, P R ^a,d   McGreavey, L ^a,e   Madrigal, J A ^a,b   Potter, M ^b   Ethell, M ^b   Prentice, H G ^b   Guimaraes A ^c   Travers, P J ^a,b  

^a ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

GVHD; Immune reconstitution; Thymus

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLERGIC REACTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; BLOOD SAMPLING; CELL COMPARTMENTALIZATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PUVA; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD CELLS; CHILD; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LONGITUDINAL STUDIES; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOPOIESIS; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; REGENERATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMUS GLAND; TRANSPLANTATION, HOMOLOGOUS;

EID: 0344465968     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704235     Document Type: Review

References (93)

1. Devine SM, Adkins DR, Khoury H et al. Recent advances inallogeneic hematopoietic stem-cell transplantation. J Lab Clin Med 2003; 141: 7-32.
2. Burnett AK, Eden OB. The treatment of acute leukaemia. Lancet 1997; 349: 270-275.
3. Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954-1956.
4. Horowitz MM, Bortin MM. The role of registries in evaluating the results of bone marrow transplantation. In: Treleaven J (ed). Bone Marrow Transplantation in Practice 1992. Churchill Livingstone: Edinburgh, pp 367-377.
5. Davies SM, Wagner JE, Shu XO et al. Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 1997; 15: 557-565.
6. Gustafsson A, Remberger M, Winiarski J, Ringden O. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transplant 2000; 25: 1059-1065.
7. Hows JM, Yin JL, Marsh J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.
8. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207-214.
9. Feinstein L, Sandmaier B, Maloney D et al. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. Ann N Y Acad Sci 2001; 938: 328-337.
10. Michallet M, Bilger K, Garban F et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 2001; 19: 3340-3349.
11. Morecki S, Gelfand Y, Nagler A et al. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. Bone Marrow Transplant 2001; 28: 243-249.
12. Nagler A, Aker M, Or R et al. Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation. Exp Hematol 2001; 29: 362-370.
13. Ash RC, Horowitz MM, Gale RP et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant 1991; 7: 443-452.
14. Gilmore MJ, Patterson J, Ivory K et al. Standardization of T-cell depletion in HLA matched bone marrow transplantation. Br J Haematol 1986; 64: 69-75.
15. Prentice HG, Blacklock HA, Janossy G et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; 1: 472-476.
16. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-550.
17. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962-968.
18. Davies SM, Shu XO, Blazar BR et al. Unrelated donor bone marrow transplantation: influence of HLA A and HLA B incompatability on outcome. Blood 1995; 86: 1636-1642.
19. Hongeng S, Krance RA, Bowman LC et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 350: 767-771.
20. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
21. Oakhill A, Pamphilon DH, Potter MN et al. Unrelated donor marrow transplanation for children with relapsed acute lymphoblastic leukaemia in second complate remmision. Br J Haematol 1996; 94: 574-578.
22. Ochs L, Shu XO, Miller J et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995; 86: 3979-3986.
23. Small TN, Avigan D, Dupont B et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant 1997; 3: 65-75.
24. Snyder DS, Chao NJ, Amylon MD et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993; 82: 2920-2928.
25. Madrigal JA, Scott I, Arguello R et al. Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997; 157: 153.
26. Korbling M, Anderlini P, Hematology TA. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 2001; 98: 2900-2908.
27. Small TN, Papadopoulos EB, Boulad F et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467-480.
28. Storek J, Espino G, Dawson MA et al. Low B-cell and monocyte counts on day 80 are associated with3 high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood 2000; 96: 3290-3293.
29. Storek J, Gooley T, Witherspoon RP et al. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997; 54: 131-138.
30. Dumont-Girard F, Roux E, van Lier RA et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood 1998; 92: 4464-4471.
31. Mackall CL, Fleisher TA, Brown MR et al. Age, thymopoiesis, and CD4 + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-149.
32. Roux E, Dumont-Girard F, Starobinski M et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000; 96: 2299-2303.
33. Niehues T, Rocha V, Filipovich AH et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children-a Eurocord analysis. Br J Haematol 2001; 114: 42-48.
34. Weinberg K, Blazar BR, Wagner JE et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001; 97: 1458-1466.
35. Douek DC, McFarland RD, Keiser PH et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396: 690-695.
36. Douek DC, Vescio RA, Betts MR et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000; 355: 1875-1881.
37. Hochberg EP, Chillemi AC, Wu CJ et al. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 2001; 98: 1116-1121.
38. Chung B, Barbara-Burnham L, Barsky L, Weinberg K. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 2001; 98: 1601-1606.
39. Baars PA, Maurice MM, Rep M et al. Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+ CD45RA-CD27- T cell subset contains specialized primed T cells. J Immunol 1995; 154: 17-25.
40. Hamann D, Baars PA, Rep MH et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186: 1407-1418.
41. Hintzen RQ, de Jong R, Lens SM et al. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993; 151: 2426-2435.
42. Gregersen PK, Hingorani R, Monteiro J. Oligoclonality in the CD8+ T-cell population. Analysis using a multiplex PCR assay for CDR3 length. Ann NY Acad Sci 1995; 756: 19-27.
43. Singer CR, Tansey PJ, Burnett AK. T lymphocyte reconstitution following autologous bone marrow transplantation. Clin Exp Immunol 1983; 51: 455-460.
44. Witherspoon RP, Lum LG, Storb R, Thomas ED. In vitro regulation of immunoglobulin synthesis after human marrow transplantation. II. Deficient T and non-T lymphocyte function within 3-4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy. Blood 1982; 59: 844-850.
45. Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol 2000; 20: 250-256.
46. Hollander GBS. Thymic T-cell development. In: Ferrara JD. HJ; Burakoff, SJ, (eds). Graft-vs-Host Disease. New York: Marcel Decker, Inc., 1997, pp 1-50.
47. Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 1997; 157: 61-72.
48. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev 1997; 160: 91-102.
49. Mackall CL, Punt JA, Morgan P et al. Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur J Immunol 1998; 28: 1886-1893.
50. Lewin SR, Heller G, Zhang L et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantation. Blood 2002; 100: 2235-2242.
51. Hulstaert F, Hannet I, Deneys V et al. Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol 1994; 70: 152-158.
52. Kurashima C, Utsuyama M, Kasai M et al. The role of thymus in the aging of Th cell subpopulations and age-associated alteration of cytokine production by these cells. Int Immunol 1995; 7: 97-104.
53. Mackall CL, Bare CV, Granger LA et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prove to skewing. J Immunol 1996; 156: 4609-4616.
54. Mackall CL, Fry TJ, Bare C et al. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001; 97: 1491-1497.
55. Atkinson K, Hansen JA, Storb R et al. T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 1982; 59: 1292-1298.
56. Connors M, Kovacs JA, Krevat S et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately arestored by antiviral or immune-based therapies. Nat Med 1997; 3: 533-540.
57. Forman SJ, Nocker P, Gallagher M et al. Pattern of T cell reconstitution following allogeneic bone marrow transplantation for acute hematological malignancy. Transplantation 1982; 34: 96-98.
58. Jendro MC, Ganten T, Matteson EL et al. Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum 1995; 38: 1242-1251.
59. Mackall CL, Fleisher TA, Brown MR et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 84: 2221-2228.
60. Globerson A. T lymphocytes and aging. Int Arch Allergy Immunol 1995; 107: 491-497.
61. Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 2000; 21: 515-521.
62. Timm JA, Thoman ML. Maturation of CD4+ lymphocytes in the aged microenvironment results in a memory-enriched population. J Immunol 1999; 162: 711-717.
63. George AJ, Ritter MA. Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today 1996; 17: 267-272.
64. Kendall MD, Johnson HR, Singh J. The weight of the human thymus gland at necropsy. J Anat 1980; 131: 483-497.
65. Steinmann GG, Klaus B, Muller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985; 22: 563-575.
66. Ferrara JLM, Deeg HJ. Graft-versus-host-disease. N Eng J Med 1991; 324: 667-674.
67. Fukushi N, Arase H, Wang B et al. Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci USA 1990; 87: 6301-6305.
68. Ghayur T, Seemayer TA, Xenocostas A, Lapp WS. Complete sequential regeneration of graft-vs-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs-host disease. Am J Pathol 1988; 133: 39-46.
69. Hollander GA, Widmer B, Burakoff SJ. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol 1994; 152: 1609-1617.
70. Muller-Hermelink HK, Sale GE, Borisch B, Storb R. Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. Am J Pathol 1987; 129: 242-256.
71. van den Brink MR, Moore E, Ferrara JL, Burakoff SJ. Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation 2000; 69: 446-449.
72. Brochu S, Rioux-Masse B, Roy J et al. Massive activation-induced cell death of alloreactive T-cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood 1999; 94: 390-400.
73. Dulude G, Roy DC, Perreault C. The effect of graft-versus-host disease on T cell production and homeostasis. J Exp Med 1999; 189: 1329-1342.
74. Krenger W, Rossi S, Piali L, Hollander GA. Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells. Blood 2000; 96: 347-354.
75. Hakim FT, Payne S, Shearer GM. Recovery of T cell populations after acute graft-vs-host reaction. J Immunol 1994; 152: 58-64.
76. Leposavic G, Obradovic S, Kosec D. In vivo modulation of the distribution of thymocyte subsets by female sex steroid hormones. Int Immunopharmacol 2001; 1: 1-12.
77. Leussink VI, Jung S, Merschdorf U et al. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch Neurol 2001; 58: 91-97.
78. Nambiar MP, Enyedy EJ, Fisher CU et al. Dexamethasone modulates TCR zeta chain expression and antigen receptor-mediated early signaling events in human T lymphocytes. Cell Immunol 2001; 208: 62-71.
79. Olsen NJ, Viselli SM, Fan J, Kovacs WJ. Androgens accelerate thymocyte apoptosis. Endocrinology 1998; 139: 748-752.
80. Szondy Z. Methylprednisolone and 2-chloroadenosine induce DNA fragmentation at different stages of human T-lymphocyte development. Immunol Lett 1997; 58: 59-65.
81. Van Laethem F, Baus E, Smyth LA et al. Glucocorticoids attenuate T cell receptor signaling. J Exp Med 2001; 193: 803-814.
82. Wiegers GJ, Stec IE, Klinkert WE et al. Bidirectional effects of corticosterone on splenic T-cell activation: critical role of cell density and culture time. Neuroendocrinology 2001; 73: 139-148.
83. Brenner MK, Grob JP, Prentice HG. The use of monoclonal antibodies in graft versus host disease prevention. Haematologia 1986; 19: 167-176.
84. Hale G, Zhang MJ, Bunjes D et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood 1998; 92: 4581-4590.
85. Urbano-Ispizua A, Carreras E, Marin P et al. Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells? Blood 2001; 98: 2352-2357.
86. Urbano-Ispizua A, Rozman C, Pimentel P et al. The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings. Blood 2001; 97: 383-387.
87. Andrew D, Aspinall R. I1-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol 2001; 166: 1524-1530.
88. Bolotin E, Smogorzewska M, Smith S et al. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996; 88: 1887-1894.
89. Okamoto Y, Douek DC, McFarland RD, Koup RA. Effects of exogenous interleukin-7 on human thymus function. Blood 2002; 99: 2851-2858.
90. Howard JK, Lord GM, Matarese G et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999; 104: 1051-1059.
91. Sfikakis PP, Kostomitsopoulos N, Kittas C et al. Tamoxifen exerts testosterone-dependent and independent effects on thymic involution. Int J Immunopharmacol 1998; 20: 305-312.
92. Oehme P, Hecht K, Jumatov J et al. Prevention of stress-induced involution of the thymus in rats by substance P (SP1-11) and its N-terminal fragment SP1-4. Pharmazie 1987; 42: 34-36.
93. Min D, Taylor P, Chung B et al. Protection from thymic epithelial cell injury by pre-BMT keratinocyte growth factor: a new approach to speed thymic reconstitution after lethal irradiation. In ASH San Francisco: Blood, 2000, pp 474a.